Abstract
We report on a 41 year old woman, who after 750 mg mefloquine, a newer antimalarial agent, developed a psychosis with dizziness, confusion and delusions. The symptoms were more intensive and remained longer than hitherto reported in the literature. A total of 23 patients are known to have had psychiatric adverse effects under mefloquine. Psychotic episodes are undoubtedly though rarely associated with the intake of mefloquine.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adult
-
Female
-
Hallucinations / chemically induced*
-
Hallucinations / drug therapy
-
Hallucinations / psychology
-
Haloperidol / administration & dosage
-
Humans
-
Malaria / prevention & control*
-
Mefloquine / administration & dosage
-
Mefloquine / adverse effects*
-
Perazine / administration & dosage
-
Psychoses, Substance-Induced / drug therapy
-
Psychoses, Substance-Induced / etiology*
-
Psychoses, Substance-Induced / psychology
-
Recurrence
-
Risk Factors
Substances
-
Perazine
-
Haloperidol
-
Mefloquine